Reactivation of hepatitis B virus replication during peginterferon- ribavirin therapy in an HIV/hepatitis C virus-co-infected patient with isolated anti-hepatitis B core antibodies

AIDS

Volumn 21, Issue 3, 2007, Pages 393-394

  Chakvetadze, Catherine ^a   Bani Sadr, Firouzé ^a   Le Pendeven, Catherine ^a   Lamontagne, Franck ^a   Vincensini, Jean Paul ^a   Pialoux, Gilles ^a  

^a HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; HEPATITIS B CORE ANTIBODY; LAMIVUDINE; PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

ADULT; ANTIBODY ISOLATION; ARTICLE; CASE REPORT; COMORBIDITY; DRUG INDICATION; DRUG SUBSTITUTION; FATIGUE; FEMALE; FOLLOW UP; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAUNDICE; LABORATORY TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TREATMENT OUTCOME; VIRUS REACTIVATION; VIRUS REPLICATION;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INTERFERON ALFA-2A; POLYETHYLENE GLYCOLS; RIBAVIRIN; VIRUS ACTIVATION;

EID: 33846630451     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328012b5d3     Document Type: Article

References (9)

1. Larsen C, Pialoux G, Salmon D, Antona D, Piroth L, Le Strat Y, et al. Prevalence of hepatitis B and C virus co-infections in the HIV-positive population, France June 2004 [in French]. Bull Epidémiol Hebd 2005; 23:109-112.
2. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341:22-26.
3. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001; 34:194-203.
4. Neau D, Winnock M, Jouvencel AC, Faure M, Castera L, Legrand E, et al. Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003. Clin Infect Dis 2005; 40:750-753.
5. Wagner AA, Denis F, Weinbreck P, Loustand V, Autofage F, Rogez S, Alain S. Serological pattern 'anti-hepatitis B core alone' in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants. AIDS 2004; 18:569-571.
6. Nunez M, Rios P, Perez-Olmeda M, Soriano V. Lack of 'occult' hepatitis B virus infection in HIV-infected patients. AIDS 2002; 16:2099-2101.
7. Bani-Sadr F, Maillard A, Ponscarme D, Scieux C, Molina JM. Reactivation of HBV replication in HIV-HBV infected patients. Am J Med 2003; 114:768-769.
8. Villa E, Grottola A, Trande P, Seium Y, Rebecchi AM, Dugani A, Mananti F. Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, antiHCV-positive patients. Lancet 1993; 341:1413.
9. Yalcin K, Degertekin H, Yildiz F, Kilinc N. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin. J Gastroenterol 2003; 38: 796-800.